Salpingectomy vs Tubal Sterilisation in Low Risk for Ovarian Cancer Women and Its Effect on Ovarian Reserve

Karlstad Central Hospital100 enrolled

Overview

Randomised study to investigate if salpingectomies done to women wishing tubal sterilisation has an effect on ovarian reserve.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

PREVENTION

Masking

NONE

Enrollment

100

Conditions

Ovarian Cancer

Interventions

Bilateral SalpingectomyPROCEDURE

Tubal sterilization with bipolar energyPROCEDURE

Eligibility

Sex: FEMALEMin age: 25 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women seeking for tubal sterilisation Exclusion Criteria: * women older than 45 * family history of ovarian cancer * presence of menopausal symptoms * irregular cycles * Hormone Replacement Therapy or hormone contraceptions the last 3 months * history of previous ovarian or uterine surgeries * imaging suggesting an ovarian cyst or other adnexal pathology during investigation * previous salpingectomy

Locations (1)

Department of Obstetrics and Gynecology

Karlstad, Värmaland, Sweden

Outcomes

Primary Outcomes

Anti-Mullerian hormone (AMH)and Follicle Stimulation Hormone (FSH)

Time frame: 3 months

Secondary Outcomes

Anti-Mullerian hormone (AMH)

Time frame: 1 year

Operative time

Time frame: Postoperatively

Complications

Time frame: 3 months

Central Contacts

Leonidas Magarakis, MD

CONTACT

046737529929 lemagarakis@gmail.com

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.